Oligonucleotide analogues with cationic backbone linkages

Scholarly Works

• Miyamoto, N.; Sugito, N.; Kitade, Y.; Akao, Y. Growth inhibition of RAS-mutated hematopoietic tumor cells using glucose-attached reversibly ionic oligonucleotide-based nanoparticles caging chemically modified microRNA143-3p. Journal of Drug Delivery Science and Technology 2023, 88, 104902. doi:10.1016/j.jddst.2023.104902
• Yamaguchi, T.; Horie, N.; Aoyama, H.; Kumagai, S.; Obika, S. Mechanism of the extremely high duplex-forming ability of oligonucleotides modified with N-tert-butylguanidine- or N-tert-butyl-N'- methylguanidine-bridged nucleic acids. Nucleic acids research 2023, 51, 7749–7761. doi:10.1093/nar/gkad608
• Patrushev, D. E.; Burakova, E. A.; Bizyaev, S. N.; Fokina, A. A.; Stetsenko, D. A. New Zwitter-Ionic Oligonucleotides: Preparation and Complementary Binding. Molecular Biology 2023, 57, 320–328. doi:10.1134/s0026893323020164
• Patrushev, D. E.; Burakova, E. A.; Bizyaev, S. N.; Fokina, A. A.; Stetsenko, D. A. New Zwitter-Ionic Oligonucleotides: Preparation and Complementary Binding. Molekuliarnaia biologiia 2023, 57, 340–349. doi:10.31857/s0026898423020180
• Bremer, J.; Richter, C.; Schwalbe, H.; Richert, C. Synthesis of a Peptidoyl RNA Hairpin via a Combination of Solid-Phase and Template-Directed Chain Assembly. Chembiochem : a European journal of chemical biology 2022, 23, e202200352. doi:10.1002/cbic.202200352
• Bege, M.; Borbás, A. The Medicinal Chemistry of Artificial Nucleic Acids and Therapeutic Oligonucleotides. Pharmaceuticals (Basel, Switzerland) 2022, 15, 909. doi:10.3390/ph15080909
• De Fazio, A. F.; Misatziou, D.; Baker, Y. R.; Muskens, O. L.; Brown, T.; Kanaras, A. G. Chemically modified nucleic acids and DNA intercalators as tools for nanoparticle assembly. Chemical Society reviews 2021, 50, 13410–13440. doi:10.1039/d1cs00632k
• Debreczeni, N.; Bege, M.; Herczeg, M.; Bereczki, I.; Batta, G.; Herczegh, P.; Borbás, A. Tightly linked morpholino-nucleoside chimeras: new, compact cationic oligonucleotide analogues. Organic & biomolecular chemistry 2021, 19, 8711–8721. doi:10.1039/d1ob01174j
• Danielsen, M. B.; Wengel, J. Cationic oligonucleotide derivatives and conjugates: A favorable approach for enhanced DNA and RNA targeting oligonucleotides. Beilstein journal of organic chemistry 2021, 17, 1828–1848. doi:10.3762/bjoc.17.125
• Clavé, G.; Reverte, M.; Vasseur, J.-J.; Smietana, M. Modified internucleoside linkages for nuclease-resistant oligonucleotides. RSC chemical biology 2021, 2, 94–150. doi:10.1039/d0cb00136h
• Hawner, M.; Ducho, C. Cellular Targeting of Oligonucleotides by Conjugation with Small Molecules. Molecules (Basel, Switzerland) 2020, 25, 5963. doi:10.3390/molecules25245963
• Kumagai, S.; Sawamoto, H.; Takegawa-Araki, T.; Arai, Y.; Yamakoshi, S.; Yamada, K.; Ohta, T.; Kawanishi, E.; Horie, N.; Yamaguchi, T.; Obika, S. Synthesis and properties of GuNA purine/pyrimidine nucleosides and oligonucleotides. Organic & biomolecular chemistry 2020, 18, 9461–9472. doi:10.1039/d0ob01970d
• Patutina, O. A.; Gaponova, S.; Sen'kova, A. V.; Savin, I. A.; Gladkikh, D. V.; Burakova, E. A.; Fokina, A. A.; Maslov, M. A.; Shmendel, E. V.; Wood, M. J. A.; Vlassov, V. V.; Altman, S.; Stetsenko, D. A.; Zenkova, M. A. Mesyl phosphoramidate backbone modified antisense oligonucleotides targeting miR-21 with enhanced in vivo therapeutic potency. Proceedings of the National Academy of Sciences of the United States of America 2020, 117, 32370–32379. doi:10.1073/pnas.2016158117
• Wnuk, M.; Slipek, P.; Dziedzic, M.; Lewinska, A. The Roles of Host 5-Methylcytosine RNA Methyltransferases during Viral Infections. International journal of molecular sciences 2020, 21, 8176. doi:10.3390/ijms21218176
• Wojtyniak, M.; Schmidtgall, B.; Kirsch, P.; Ducho, C. Towards Zwitterionic Oligonucleotides with Improved Properties: the NAA/LNA-Gapmer Approach. Chembiochem : a European journal of chemical biology 2020, 21, 3234–3243. doi:10.1002/cbic.202000450
• Skakuj, K.; Bujold, K. E.; Mirkin, C. A. Automated Synthesis and Purification of Guanidine-Backbone Oligonucleotides. Current protocols in nucleic acid chemistry 2020, 81, e110. doi:10.1002/cpnc.110
• Skakuj, K.; Bujold, K. E.; Mirkin, C. A. Mercury-Free Automated Synthesis of Guanidinium Backbone Oligonucleotides. Journal of the American Chemical Society 2019, 141, 20171–20176. doi:10.1021/jacs.9b09937
• Jahanban-Esfahlan, A.; Seidi, K.; Jaymand, M.; Schmidt, T.; Majdi, H.; Javaheri, T.; Jahanban-Esfahlan, R.; Zare, P. Dynamic DNA nanostructures in biomedicine: Beauty, utility and limits. Journal of controlled release : official journal of the Controlled Release Society 2019, 315, 166–185. doi:10.1016/j.jconrel.2019.10.003
• Soler-Bistué, A.; Zorreguieta, A.; Tolmasky, M. E. Bridged Nucleic Acids Reloaded. Molecules (Basel, Switzerland) 2019, 24, 2297. doi:10.3390/molecules24122297
• Arangundy-Franklin, S.; Taylor, A. I.; Porebski, B. T.; Genna, V.; Peak-Chew, S. Y.; Vaisman, A.; Woodgate, R.; Orozco, M.; Holliger, P. A synthetic genetic polymer with an uncharged backbone chemistry based on alkyl phosphonate nucleic acids. Nature chemistry 2019, 11, 533–542. doi:10.1038/s41557-019-0255-4

Explore citations to this article at